152 related articles for article (PubMed ID: 36113553)
1. p-TAK1 acts as a switch between myoblast proliferation phase and differentiation phase in mdx mice via regulating HO-1 expression.
Fan S; Huang X; Tong H; Hong H; Lai Z; Hu W; Liu X; Zhang L; Jiang Z; Yu Q
Eur J Pharmacol; 2022 Oct; 933():175277. PubMed ID: 36113553
[TBL] [Abstract][Full Text] [Related]
2. TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.
Xu D; Li S; Wang L; Jiang J; Zhao L; Huang X; Sun Z; Li C; Sun L; Li X; Jiang Z; Zhang L
J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):192-208. PubMed ID: 33236534
[TBL] [Abstract][Full Text] [Related]
3. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
[TBL] [Abstract][Full Text] [Related]
4. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.
Xu DQ; Zhao L; Li SJ; Huang XF; Li CJ; Sun LX; Li XH; Zhang LY; Jiang ZZ
Acta Pharmacol Sin; 2021 Jul; 42(7):1080-1089. PubMed ID: 32939036
[TBL] [Abstract][Full Text] [Related]
5. A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.
Xu D; Zhao L; Jiang J; Li S; Sun Z; Huang X; Li C; Wang T; Sun L; Li X; Jiang Z; Zhang L
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1306-1320. PubMed ID: 32869445
[TBL] [Abstract][Full Text] [Related]
6. Effect of heme oxygenase-1 on the differentiation of human myoblasts and the regeneration of murine skeletal muscles after acute and chronic injury.
Głowniak-Kwitek U; Caballero AL; Bronisz-Budzyńska I; Kozakowska M; Andrysiak K; Stępniewski J; Łoboda A; Dulak J
Pharmacol Rep; 2023 Apr; 75(2):397-410. PubMed ID: 36918494
[TBL] [Abstract][Full Text] [Related]
7. Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model.
Roy A; Koike TE; Joshi AS; Tomaz da Silva M; Mathukumalli K; Wu M; Kumar A
JCI Insight; 2023 May; 8(10):. PubMed ID: 37071470
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.
Bhatnagar S; Kumar A; Makonchuk DY; Li H; Kumar A
J Biol Chem; 2010 Feb; 285(9):6401-11. PubMed ID: 20037161
[TBL] [Abstract][Full Text] [Related]
9. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) interact with the promyogenic receptor Cdo to promote myogenic differentiation via activation of p38MAPK pathway.
Tran P; Ho SM; Kim BG; Vuong TA; Leem YE; Bae GU; Kang JS
J Biol Chem; 2012 Apr; 287(15):11602-15. PubMed ID: 22337877
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase and carbon monoxide protect from muscle dystrophy.
Chan MC; Ziegler O; Liu L; Rowe GC; Das S; Otterbein LE; Arany Z
Skelet Muscle; 2016 Nov; 6(1):41. PubMed ID: 27906108
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific deletion of SLK/Stk2 enhances p38 activity and myogenesis in mdx mice.
Pryce BR; Labrèche C; Hamoudi D; Abou-Hamad J; Al-Zahrani KN; Hodgins JJ; Boulanger-Piette A; Bossé S; Balog-Alvarez C; Frénette J; Ardolino M; Kornegay JN; Sabourin LA
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118917. PubMed ID: 33259860
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.
McRae N; Forgan L; McNeill B; Addinsall A; McCulloch D; Van der Poel C; Stupka N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211034
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
16. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.
Greco S; De Simone M; Colussi C; Zaccagnini G; Fasanaro P; Pescatori M; Cardani R; Perbellini R; Isaia E; Sale P; Meola G; Capogrossi MC; Gaetano C; Martelli F
FASEB J; 2009 Oct; 23(10):3335-46. PubMed ID: 19528256
[TBL] [Abstract][Full Text] [Related]
17. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
18. miR-22 regulates C2C12 myoblast proliferation and differentiation by targeting TGFBR1.
Wang H; Zhang Q; Wang B; Wu W; Wei J; Li P; Huang R
Eur J Cell Biol; 2018 May; 97(4):257-268. PubMed ID: 29588073
[TBL] [Abstract][Full Text] [Related]
19. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
20. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
